MOTS-c
Studied for: mitochondrial signaling
MOTS-c is a peptide encoded in mitochondrial DNA. Research examines its role as a signal between the mitochondria and the nucleus, particularly under metabolic stress.
Last reviewed September 26, 2026
How it is thought to work
Research describes MOTS-c as translocating to the nucleus under metabolic stress, where it is studied for effects on genes governing metabolic homeostasis, largely via AMPK-associated pathways.
- Mitochondrial OriginEncoded within mitochondrial DNA and studied as a signal between the mitochondria and the rest of the cell.
- Metabolic ResponseExplored in research on AMPK-associated pathways governing how cells manage energy availability and stress.
- Route studied
- Subcutaneous
- Research status
- Preclinical
Published research on MOTS-c consists mainly of animal and cell studies along with review articles, and no late-stage clinical trials or regulatory approvals are described.
Research
What the research covers
What research examines
- Metabolic homeostasis, obesity and insulin resistance in animal models
- Hyperglycemia and insulin resistance in gestational diabetes research
- Pancreatic islet cell senescence and diabetes onset
- Bone metabolism regulation
- Lung ischemia-reperfusion injury and antioxidant gene activation
- Ovarian cancer progression in laboratory studies
Reported effects in studies
- Human safety data are limited
- Adverse events are not summarized in the cited studies
- Long-term effects in humans have not been characterized
Studied range
What research protocols have used
Research protocols have used 500–5,000 mcg per administration, 3 times per week (morning, fasted), in 8-week blocks with 4 weeks off.
For research use only. These figures summarize published research protocols. They are not instructions or medical advice.
Every CoreX order ships with a per-lot protocol guide.
Open the reconstitution calculatorRelated compounds
Researched alongside
- TirzepatideTirzepatide is studied as a dual agonist at the GIP and GLP-1 receptors. Research examines whether combining the two incretin pathways differs from GLP-1 agonism alone.Read profile$139
- NAD+NAD+ is a coenzyme central to how cells convert fuel into usable energy. Research examines its role in redox reactions, mitochondrial output, and the repair pathways associated with biological aging.Read profile$99
- SLU-PP-332SLU-PP-332 is studied as an agonist of estrogen-related receptors, a family associated with the metabolic adaptations that follow endurance exercise.Read profile
- SS-31SS-31, also known as elamipretide, is studied for its affinity for the inner mitochondrial membrane. Research focuses on cardiolipin, a phospholipid central to mitochondrial efficiency.Read profile$329
Studies
Cited research
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
Cell metabolism · 2015 · PMID 25738459
- Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging.
Journal of translational medicine · 2023 · Review · PMID 36670507
- The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus.
Pharmacological research · 2022 · PMID 34798268
- Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes.
Experimental & molecular medicine · 2025 · PMID 40855115
- MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes.
Redox biology · 2025 · PMID 40403491
FAQ
Questions about MOTS-c
MOTS-c is a peptide encoded within mitochondrial DNA rather than nuclear DNA. It is classed as a mitochondrial-derived peptide and is studied as a signaling molecule that carries information between the mitochondria and the rest of the cell. Research interest centers on its role under metabolic stress, where it has been examined for effects on how cells manage energy availability, and it is generally grouped with compounds studied in longevity and metabolic research.
Research describes MOTS-c as translocating to the nucleus when cells are under metabolic stress. Once there, it has been studied for effects on genes that govern metabolic homeostasis, largely through AMPK-associated pathways that help regulate cellular energy balance. One lung injury study reported nuclear translocation dependent on MYH9 and activation of antioxidant genes. These mechanisms come primarily from animal and cell research and have not been confirmed in human trials.
A frequently cited study reported that MOTS-c promoted metabolic homeostasis and reduced obesity and insulin resistance in experimental models. Other work has examined hyperglycemia and insulin resistance in gestational diabetes, pancreatic islet cell senescence and diabetes onset, bone metabolism, lung ischemia-reperfusion injury, sepsis-induced cardiomyopathy, and ovarian cancer progression. Several reviews also discuss its links to stress, metabolism and aging. This work is largely preclinical, and findings should not be taken as established human outcomes.
Human safety data for MOTS-c are limited. The available literature is dominated by animal studies, cell experiments and reviews, and adverse events are not summarized in the cited studies. Long-term effects, interactions and contraindications in humans have not been characterized. Because of these gaps, the safety profile of MOTS-c remains uncertain, and conclusions drawn from preclinical models may not reflect effects in people.
Research protocols have used 500 to 5,000 mcg per administration by the subcutaneous route, three times per week in the morning under fasted conditions. These protocols have been run in 8-week blocks followed by 4 weeks off. This information describes published research practice only and is not a recommendation. Each CoreX order ships with a protocol guide for laboratory reference.
Ask about MOTS-c
Plain answers from our library: the science, the studied ranges and our products. It can be wrong, and it does not give medical advice.
AI answers can be wrong. Research use only.
Compare
Related comparisons
- NAD+ vs MOTS-cNAD+ and MOTS-c are both studied in longevity and metabolic research, but they differ in kind. NAD+ is a coenzyme that acts as an electron carrier in the reactions releasing energy from nutrients and serves as a required substrate for sirtuin enzymes. MOTS-c is a peptide encoded in mitochondrial DNA, described as translocating to the nucleus under metabolic stress, where it is studied for effects on metabolic genes largely via AMPK-associated pathways. NAD+ has been studied for cellular energy metabolism, sirtuin activity, and aging-related metabolic decline and neurodegeneration. MOTS-c has been studied mainly in animal and cell models of obesity, insulin resistance, bone metabolism, and lung injury. Human safety data are limited for both.
- SS-31 vs MOTS-cSS-31, also known as elamipretide, and MOTS-c are both peptides studied in mitochondrial and longevity research, but they are described as acting in different ways. SS-31 is researched for concentrating in the inner mitochondrial membrane and interacting with cardiolipin, a phospholipid that shapes membrane structure. Studies have examined its effects on electron-transport efficiency and oxidative stress. MOTS-c is a peptide encoded in mitochondrial DNA and is studied as a signal that translocates to the nucleus under metabolic stress, with research focused on AMPK-associated pathways. SS-31 has been evaluated in a phase 3 trial in primary mitochondrial myopathy and in heart failure research. MOTS-c research, mainly in animal and cell models, has examined obesity, insulin resistance, bone metabolism and islet cell senescence.